BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33318925)

  • 1. COVID-19 in patients with acute leukemia: Two cases with different outcomes.
    Rajasurya V; Elliott K; Dugan J; Moreb JS
    Leuk Res Rep; 2021; 15():100232. PubMed ID: 33318925
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 infection in patients with acute leukemia; Istanbul experience.
    Buyuktas D; Acar K; Sucak G; Toptas T; Kapucu I; Bekoz H; Erdem S; Nalcaci M; Atalay F; Akay MO; Ferhanoglu B
    Am J Blood Res; 2021; 11(4):427-437. PubMed ID: 34540352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment for acute leukemia showing PCR-positivity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) at initial diagnosis: a case report and review of literature].
    Onaka T; Otsuka Y; Miyakawa N; Ogura A; Iwai F; Yonezawa A
    Rinsho Ketsueki; 2021; 62(11):1604-1608. PubMed ID: 34866083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could COVID-19 induce remission of acute leukemia?
    Kandeel EZ; Refaat L; Abdel-Fatah R; Samra M; Bayoumi A; Abdellateif MS; Abdel-Hady H; Ali M; Khafagy M
    Hematology; 2021 Dec; 26(1):870-873. PubMed ID: 34719343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chemotherapy on lymphocytes and serological memory in recovered COVID-19 patients with acute leukemia.
    Liu W; Li Z; He W; Yu D; Wang P; Cai L; Yang P; Chen X; Zhang X; Zhou H
    J Cancer; 2021; 12(8):2450-2455. PubMed ID: 33758621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
    Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S
    Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Possible Effects of the COVID-19 Pandemic on Febrile Neutropenia Episodes in Children With Acute Leukemia.
    Erbaş İC; Tüfekçi Ö; Akyol Ş; Asrak HK; Güzin AÇ; Alataş ŞÖ; Yilmaz Ş; Ören H; Belet N
    J Pediatr Hematol Oncol; 2022 Oct; 44(7):e976-e981. PubMed ID: 34654763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: High-risk acute promyelocytic leukemia and COVID-19-related myocarditis one patient, two cytokine storms.
    Ghiaur A; Doran C; Ionescu B; Mohorea-Neata LA; Stancioaica C; Hirjan R; Tatic A; Cirstea M; Vasilache D; Tabac D; Lupescu I; Coriu D
    Front Oncol; 2023; 13():1095154. PubMed ID: 37114131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SOME CYTOGENETIC PARAMETERS IN CHILDREN WITH ACUTE LEUKEMIA ASSOCIATED WITH COVID-19 INFECTION (CASE REPORTS)].
    Zedginidze A; Shengelaia A; Jashiashvili S
    Georgian Med News; 2021; (316-317):119-123. PubMed ID: 34511457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single Institution.
    Drozd-Sokołowska J; Mądry K; Barankiewicz J; Kobylińska K; Biecek P; Rytel J; Karakulska-Prystupiuk E; Skwierawska K; Salomon-Perzyński A; Stokłosa T; Basak GW
    Chemotherapy; 2023; 68(1):16-22. PubMed ID: 36103840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.
    Stahl M; Narendra V; Jee J; Derkach A; Maloy M; Geyer MB; Mato AR; Roeker LE; Tallman MS; Shah GL; Daniyan A; Goldberg AD
    Leuk Lymphoma; 2021 Aug; 62(8):1940-1948. PubMed ID: 34180767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries.
    Demichelis-Gómez R; Alvarado-Ibarra M; Vasquez-Chávez J; Delgado-López N; Gómez-Cortés C; Espinosa-Bautista K; Cooke-Tapia A; Milán-Salvatierra A; Gómez-De León A; Lee-Tsai YL; Rosales-López D; Cabrera-García Á; Amador-Medina F; Córdoba-Ramírez A; Murrieta-Álvarez I; Solís-Poblano JC; Apodaca-Chávez E; Rangel-Patiño J; Álvarez-Vera JL; Arana-Luna L; De la Peña-Celaya JA; Espitia-Ríos ME; Hernández-Ruiz E; Pérez-Zúñiga JM; Peña-López E; González-Rivera R; García-Leyva MF; Tejeda-Romero M; Cruz-Rico J; Balderas-Delgado C; Ruíz-Argüelles GJ; Gómez-Almaguer D
    JCO Glob Oncol; 2021 Apr; 7():577-584. PubMed ID: 33891480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 and chronic myeloid leukemia: a systematic review.
    Ali EA; Al-Sadi A; Al-Maharmeh Q; Subahi EA; Bellamkonda A; Kalavar M; Panigrahi K; Alshurafa A; Yassin MA
    Front Med (Lausanne); 2023; 10():1280271. PubMed ID: 38327268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent Diagnosis of Acute Myeloid Leukemia and Symptomatic COVID-19 Infection: a Case Report Successfully Treated with Azacitidine-Venetoclax Combination.
    Taurino D; Frigeni M; Grassi A; Cavallaro G; Salmoiraghi S; Spinelli O; Rambaldi A; Lussana F
    Mediterr J Hematol Infect Dis; 2021; 13(1):e2021057. PubMed ID: 34527209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Maternal and perinatal outcomes in pregnant women with leukemia].
    Nomura RM; Igai AM; Faciroli NC; Aguiar IN; Zugaib M
    Rev Bras Ginecol Obstet; 2011 Aug; 33(8):174-81. PubMed ID: 22159617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hidden burden of disease in a specific group: Evaluation of COVID-19 seroconversion rates in pediatric patients with leukemia.
    Yılmaz Çelebi M; Şahinkaya Ş; Cem E; Akaslan Kara A; Özdağ E; Ayhan FY; Karakaya N; Odaman Al I; Gözmen S; Hilkay Karapınar T; Oymak Y; Bayram SN; Devrim İ
    Am J Infect Control; 2024 Mar; 52(3):320-323. PubMed ID: 37726054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel coronavirus infection (COVID-19) in a 12-year-old boy with acute lymphoblastic leukemia.
    Marhaeni W; Abdiwati NMY; Wijaya AB
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S478-S480. PubMed ID: 36511009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.
    Ribera JM; Morgades M; Coll R; Barba P; López-Lorenzo JL; Montesinos P; Foncillas MA; Cabrero M; Gómez-Centurión I; Morales MD; Varela MR; Herrera P; García-Cadenas I; Calbacho M; Torrent A; Maluquer C; Calabuig M; Garcia-Guiñon A; Bautista G; Llorente L; Gil C; Artola MT; González-Campos J; Fernández-Moreno A; Bárez A; Giménez-Pérez T; Bergua J; Sánchez-Sánchez MJ; Mateos MC; Piñana JL
    Clin Lymphoma Myeloma Leuk; 2021 Oct; 21(10):e801-e809. PubMed ID: 34376375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress.
    Modemann F; Ghandili S; Schmiedel S; Weisel K; Bokemeyer C; Fiedler W
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to
    Aldoss I; Stiller T; Tsai NC; Song JY; Cao T; Bandara NA; Salhotra A; Khaled S; Aribi A; Al Malki MM; Mei M; Ali H; Spielberger R; O'Donnell M; Snyder D; Slavin T; Nakamura R; Stein AS; Forman SJ; Marcucci G; Pullarkat V
    Haematologica; 2018 Oct; 103(10):1662-1668. PubMed ID: 29903756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.